Candrilli SD, O'Brien SH, Balkrishnan R. Economic outcomes associated with hydroxyurea adherence among pediatric Medicaid enrollees with sickle cell disease. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A463.
Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010 Jul 27;7(7):e1000316.
Davis KL, Mitra D, Leteneux C, Bapat B, Naujoks C. Medical service utilization and costs by disease severity, sustained viral response, and genotype in European patients with chronic hepatitis c virus. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010. [abstract] Value Health. 2010 May; 13(3):A71.
Jeuland M, Maskery B, Cook J, Poulos C, Clemens J, Lauria D, Stewart J, Lucas M, Whittington D. Incorporating cholera vaccine herd protection into economic cost-benefit and cost-effectiveness models. Procedia Vaccinol. 2010;2(2010):140-6. doi: 10.1016/j.provac.2010.07.006